TGIFF (1933 Industries) ROC (Joel Greenblatt) %: 13.32% (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is 1933 Industries ROC (Joel Greenblatt) %?

1933 Industries TGIFF -3.70% ROC (Joel Greenblatt) % is 13.32% as of Apr. 2026. The stock has 2 warning signs investors should review. Among 983 Drug Manufacturers companies, 1933 Industries ranks worse than 69.38% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. 1933 Industries's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2026 was 13.32%.

The historical rank and industry rank for 1933 Industries's ROC (Joel Greenblatt) % or its related term are showing as below:

TGIFF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -154.74   Med: -63.61   Max: 5.88
Current: -0.51

During the past 13 years, 1933 Industries's highest ROC (Joel Greenblatt) % was 5.88%. The lowest was -154.74%. And the median was -63.61%.

TGIFF's ROC (Joel Greenblatt) % is ranked worse than
69.38% of 983 companies
in the Drug Manufacturers industry
Industry Median: 11.46 vs TGIFF: -0.51

1933 Industries's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


1933 Industries  (OTCPK:TGIFF) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


1933 Industries ROC (Joel Greenblatt) % Related Terms


1933 Industries ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for 1933 Industries's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

1933 Industries ROC (Joel Greenblatt) % Chart

1933 Industries Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.86 -71.43 -75.74 -15.03 5.88

1933 Industries Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.22 -13.91 8.42 -10.14 13.32

TGIFF vs ZTS, UTHR: ROC (Joel Greenblatt) % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, 1933 Industries's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


1933 Industries ROC (Joel Greenblatt) % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 1933 Industries's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where 1933 Industries's ROC (Joel Greenblatt) % falls into.



1933 Industries ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jan. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.059 + 2.562 + 0.277) - (2.655 + 0 + 0)
=1.243

Working Capital(Q: Apr. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.365 + 2.33 + 0.33) - (2.353 + 0 + 0.00099999999999989)
=1.671

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of 1933 Industries for the quarter that ended in Apr. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Apr. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jan. 2026  Q: Apr. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1.108/( ( (6.843 + max(1.243, 0)) + (6.877 + max(1.671, 0)) )/ 2 )
=1.108/( ( 8.086 + 8.548 )/ 2 )
=1.108/8.317
=13.32 %

Note: The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 13.32% mean?
1933 Industries (TGIFF) has a ROC (Joel Greenblatt) % of 13.32% as of Apr. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on 1933 Industries and its competitors. According to the industry distribution chart, 1933 Industries ranks #682 out of 983 companies in the Drug Manufacturers industry, placing it in the top 69.4%.
Is 1933 Industries' ROC (Joel Greenblatt) % too high?
1933 Industries' current ROC (Joel Greenblatt) % is 13.32%. The Drug Manufacturers industry median ROC (Joel Greenblatt) % is 11.46. 1933 Industries' value of 13.32% is 16.2% above this industry median. Based on the distribution chart, 1933 Industries ranks #682 out of 983 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does 1933 Industries' ROC (Joel Greenblatt) % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, 1933 Industries ranks #682 out of 983 companies for ROC (Joel Greenblatt) %. This places 1933 Industries in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 11.46. 1933 Industries' value of 13.32% is 16.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Drug Manufacturers company?
The median ROC (Joel Greenblatt) % among Drug Manufacturers companies is 11.46, based on 983 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 1933 Industries's current ROC (Joel Greenblatt) % of 13.32% is 16.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on 1933 Industries and its competitors. For the Drug Manufacturers industry, the median ROC (Joel Greenblatt) % is 11.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 1933 Industries's current ROC (Joel Greenblatt) % is 13.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 1933 Industries stock overvalued right now?
Based on GuruFocus' analysis, 1933 Industries (TGIFF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 48% below its estimated fair value. The current ROC (Joel Greenblatt) % is 13.32% and 16.2% above the Drug Manufacturers industry median of 11.46. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For 1933 Industries (TGIFF), the current ROC (Joel Greenblatt) % is 13.32% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

1933 Industries Business Description

Other Exchanges TGIF:Canada
Address 1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 2E9
1933 Industries Inc is a vertically integrated cannabis company. The company is focused on the cultivation and manufacturing of cannabis consumer-branded goods. The Company operates in three segments, referred to as AMA, Infused MFG, and Corporate. AMA is focused on the cultivation and sale of medical and adult-use cannabis products, and Infused MFG is focused on the manufacturing of hemp-derived CBD products. The majority of revenue is generated from the AMA segment. The operations of AMA and Infused MFG are located in the United States. All revenues are earned in the United States.